← Back to Search

Project TRAC: Tracking and Reducing Alcohol Consumption for AIDS (TRAC Trial)

N/A
Waitlist Available
Led By Carolyn Lauckner, PhD
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 8-week post-test, 16-week follow-up
Awards & highlights

TRAC Trial Summary

This trial will aim to reduce alcohol use among people living with HIV/AIDS, in order to improve treatment adherence and outcomes.

Eligible Conditions
  • AIDS
  • HIV/AIDS
  • Alcohol Consumption

TRAC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 8-week post-test, 16-week follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 8-week post-test, 16-week follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Average Blood Alcohol Content
Alcohol Use Disorder
Change in daily alcohol consumption
Secondary outcome measures
Change in CD4 count
Change in Daily HIV/AIDS Medication adherence
Change in HIV/AIDS Medication adherence
+1 more
Other outcome measures
Change in Anxiety Symptoms
Change in Coping Behaviors
Change in Depressive Symptomology
+3 more

TRAC Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist Control GroupExperimental Treatment1 Intervention
Receives the "Project TRAC: Tracking and Reducing Alcohol Consumption" alcohol reduction intervention after an 8-week, assessment-only period. This 8-wek intervention focuses on skill building and motivational enhancement for reducing alcohol consumption.
Group II: Immediate Intervention GroupExperimental Treatment1 Intervention
Receives the eight-week intervention, "Project TRAC: Tracking and Reducing Alcohol Consumption," immediately upon enrollment. This intervention focuses on skill building and motivational enhancement for reducing alcohol consumption.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Project TRAC: Tracking and Reducing Alcohol Consumption
2019
N/A
~50

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
799 Previous Clinical Trials
1,362,461 Total Patients Enrolled
2 Trials studying AIDS
141 Patients Enrolled for AIDS
University of KentuckyLead Sponsor
185 Previous Clinical Trials
226,592 Total Patients Enrolled
Carolyn LaucknerLead Sponsor
2 Previous Clinical Trials
445 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial still recruiting participants?

"According to the clinicaltrials.gov website, this clinical trial is currently inviting participants. The original posting date was June 5th 2019, with the latest update made on September 26th 2022."

Answered by AI

How many participants are enrolling in this experiment?

"Correct. Per the details on clinicaltrials.gov, this study is still open for recruitment and was initially posted on June 5th 2019 with its last update being September 26th 2022. The research team seeks to recruit 60 participants at one site."

Answered by AI

What is the chief goal of this clinical research?

"This investigation will be monitored over a baseline, 8-week post-test and 16 week follow up phase. The primary objective is to examine the variation in daily alcohol consumption. Secondary goals include an analysis of changes in HIV/AIDS medication adherence (self reported percentage taken from a 0 to 100% scale), CD4 cell count as recorded on medical charts, and daily self-reported intake of HIV/AIDS medicine."

Answered by AI
~9 spots leftby Apr 2025